Volume 4 Number 4
Editorial
73
Observational studies of drug-eluting stents – some are more equal than others.EuroInterv.2009;4:419-423
EAPCI column
74
As time goes on... reflections. A greeting and ongoing wish-list from your EAPCIEuroInterv.2009;4:425-426
Focus article
75
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007EuroInterv.2009;4:427-436
Clinical research
76
Effect of percutaneous mitral repair with the MitraClip® device on mitral valve area and gradientEuroInterv.2009;4:437-442
78
Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents – results of the multicentre FRIEND registryEuroInterv.2009;4:449-456
79
Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcomeEuroInterv.2009;4:457-463
80
The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n=6129)EuroInterv.2009;4:464-474
81
Dual quantitative coronary angiography: a novel approach to quantify intracoronary thrombotic burdenEuroInterv.2009;4:475-480
82
Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stentsEuroInterv.2009;4:481-484
83
Predictors for very late stent thrombosis after drug-eluting stent implantation in diabetic patientsEuroInterv.2009;4:485-491
84
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS IIEuroInterv.2009;4:492-501
86
Integration of 3D reconstruction in the SELection criteria for Excessive Crossing Times for Magnetically Supported Percutaneous Coronary Intervention. SELECT-MPEuroInterv.2009;4:509-516
87
Magnetically navigated percutaneous coronary intervention in distal and/or complex lesions may improve procedural outcome and material consumptionEuroInterv.2009;4:517-523
88
Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary interventionEuroInterv.2009;4:524-528
Expert review
89
Current and future developments in intracoronary optical coherence tomography imagingEuroInterv.2009;4:529-534
Experimental research
90
In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary modelEuroInterv.2009;4:534-541
How should I treat?
91
Coronary steal with unstable angina secondary to a coronary artery fistula EuroInterv.2009;4:542-548
Volume 4 Number 4 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Biotronik AG
- Cordis, a Johnson & Johnson company
- Hexacath
- Medtronic
- Terumo



